Congress funds free smoking cessation for 70 million Medicaid beneficiaries
S. 2064 — Helping Tobacco Users Quit Act · Filed by Lisa Blunt Rochester (D-DE) · 1 cosponsor · Introduced Jun 12, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires Medicaid and CHIP (Children's Health Insurance Program) to cover tobacco cessation services—including counseling, prescription drugs, and FDA-approved over-the-counter smoking-cessation medications—at no cost to beneficiaries. The federal government will pay 90% of state costs for these services and related outreach campaigns for five years, then revert to standard matching rates. States must also monitor usage and run awareness campaigns, and cannot require prior authorization for cessation drugs.
Why we flagged it
The bill's core mechanism is straightforward: it mandates Medicaid/CHIP coverage of tobacco cessation services and funds state outreach. This is a direct public-health intervention, not a tax provision, regulatory carve-out, or commemorative measure.
What the text implies
- Tobacco companies face potential long-term demand reduction if cessation rates rise significantly among Medicaid/CHIP populations, which represent ~40% of U.S. smokers. This may accelerate industry shift toward alternative nicotine products.
- States will incur administrative costs for outreach and monitoring beyond the 90% federal match, creating ongoing state-budget pressure after the 5-year enhanced match period ends.
The full analysis lists 4 implications of this text.
Who stands to gain
pharmaceutical companies (cessation drug manufacturers); healthcare providers (counseling services); state Medicaid programs (federal cost-sharing reduces state burden)